Norges Bank’s Century Therapeutics IPSC Stock Holding History

Norges Bank’s Portfolio IPSC Stock Details IPSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,000	Closed	-$293K	–	2315
2021 Q2	$293K	Buy	+10,000	New	+$254K	﹤0.01%	2188

Other funds holding IPSC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Norges Bank's IPSC Position: Q3 2021 in Review

Norges Bank sold out of Century Therapeutics (IPSC) in Q3 2021, closing a stake of 10,000 shares — an estimated $293K sold.

Norges Bank first reported a position in IPSC in Q2 2021 and held it in 1 quarter. The position peaked at $293K in Q2 2021. 49 funds tracked by Wall St. Rank hold IPSC as of Q3 2021.

Norges Bank reported no remaining Century Therapeutics position as of Q3 2021 after selling out during the quarter.
Norges Bank sold 10,000 Century Therapeutics shares in Q3 2021, an estimated $293K.
Norges Bank first reported a position in Century Therapeutics in Q2 2021 and held it in 1 quarter.
Norges Bank's Century Therapeutics position peaked at $293K in Q2 2021.
49 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2021.

Based on Norges Bank's 13F filing for Q3 2021, filed 5 Nov 2021.